Ionis Pharmaceuticals, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
IONS Nasdaq 2830 www.ionispharma.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Ionis Pharmaceuticals, Inc.

Ionis Pharmaceuticals (IONS) Expected to Beat Earnings Estimates: Should You Buy? - Feb 12th, 2025 3:00 pm
Why Insiders Are Selling Ionis Pharmaceuticals, Inc. (IONS) Recently - Feb 11th, 2025 6:59 pm
Why Ionis Pharmaceuticals, Inc. (IONS) Is Among the Best Healthcare Stocks To Buy According to Analysts - Feb 8th, 2025 2:28 pm
Ionis to hold fourth quarter and full year 2024 financial results webcast - Feb 5th, 2025 12:05 pm
FDA and EMA Accept Applications for Higher Dose Regimen of Nusinersen in SMA - Jan 23rd, 2025 12:30 pm
Why Ionis Pharmaceuticals (IONS) Is the Biotech Stock with Biggest Upside Potential - Jan 17th, 2025 4:22 pm
Ionis enters new chapter in 2025 as commercial-stage biotech with multiple independent product launches anticipated and continued late-stage pipeline momentum - Jan 13th, 2025 1:00 pm
Catalyst (CPRX) Soars 16.7%: Is Further Upside Left in the Stock? - Jan 9th, 2025 1:17 pm
Ionis to present at 43rd Annual J.P. Morgan Healthcare Conference - Jan 8th, 2025 9:11 pm
Are Investors Undervaluing Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) By 30%? - Dec 23rd, 2024 1:42 pm
FDA approves Ionis’ TRYNGOLZA for FCS treatment - Dec 20th, 2024 3:23 pm
Ionis Gets FDA Approval for Rare Disease Drug Tryngolza - Dec 20th, 2024 1:03 pm
FDA Approves Ionis Pharmaceuticals' Rare Genetic Disease Therapy to Lower High-Level Of Fat In Blood - Dec 20th, 2024 12:24 pm
TRYNGOLZA™ (olezarsen) approved in U.S. as first-ever treatment for adults living with familial chylomicronemia syndrome as an adjunct to diet - Dec 19th, 2024 11:28 pm
Theravance Bio (TBPH) Up 3.7% Since Last Earnings Report: Can It Continue? - Dec 12th, 2024 4:30 pm
How Much Upside is Left in Ionis Pharmaceuticals (IONS)? Wall Street Analysts Think 55.91% - Dec 11th, 2024 2:55 pm
Ionis Pharmaceuticals (IONS) Down 4.5% Since Last Earnings Report: Can It Rebound? - Dec 6th, 2024 4:31 pm
Theratechnologies enters exclusive licensing agreement with Ionis - Dec 5th, 2024 12:35 pm
Ionis Pharmaceuticals (IONS) Upgraded to Buy: What Does It Mean for the Stock? - Nov 27th, 2024 5:00 pm
Why Is Ionis Pharmaceuticals, Inc. (IONS) Among the Worst Performing Biotech Stocks in 2024? - Nov 21st, 2024 10:22 pm